Akebia Therapeutics | AKBA - Efectivo Y Equivalentes





Efectivo Y Equivalentes Cambio Fecha
Acadia Pharmaceuticals USD 819.69M 27.33M 2025-12
Agios Pharmaceuticals USD 89.13M 3.58M 2025-12
Akebia Therapeutics USD 184.84M 18.4M 2025-12
Alnylam Pharmaceuticals USD 1.66B 167M 2025-12
Amgen USD 9.13B 316M 2025-12
Ardelyx USD 68M 25.28M 2025-12
Astellas Pharma JPY 188.37B 8.51B 2025-03
AstraZeneca USD 8.14B 1.08B 2025-09
Bayer EUR 5.9B 1.34B 2025-09
BioMarin Pharmaceutical USD 1.31B 61.57M 2025-12
Celltrion KRW 29.65B 799.42B 2025-06
Cspc Pharmaceutical CNY 7.57B 793.73M 2025-06
Deva Holding AS TRY 775.92M 574.67M 2023-09
Dianthus Therapeutics USD 51.09M 4.9M 2025-12
Exelixis USD 482.49M 106.19M 2025-12
Fresenius Medical Care EUR 1.58B 326.57M 2025-12
GlaxoSmithKline GBP 3.3B 303M 2025-09
Ionis Pharmaceuticals USD 2.68B 437M 2025-12
Ironwood Pharmaceuticals USD 140.41M 47.56M 2025-09
J&J USD 19.71B 1.48B 2025-12
Kangmei Pharma CNY 1.18B 278M 2025-09
Karyopharm Therapeutics USD 37.67M 1.05M 2025-09
Knight Therapeutics CAD 76.45M 5.43M 2025-12
Laboratorios Farma EUR 46.11M 18.92M 2025-06
Lexicon Pharmaceuticals USD 21.36M 41.52M 2025-06
Malin Corporation EUR 62.1M 26.4M 2024-12
Medical Developments International AUD 17.84M 219K 2025-06
Moderna USD 2.6B 1.46B 2025-12
Nektar Therapeutics USD 41.03M 1.96M 2025-09
Neuren Pharmaceuticals AUD 5.91M 2.76M 2025-06
Organigram Holdings CAD 7.58M 20.62M 2025-12
Pharma Mar EUR 17.82M 3.78M 2025-12
Prothena USD 307.53M 23.31M 2025-12
PTC Therapeutics USD 984.65M 312.03M 2025-12
Qiagen NV USD 1.36B 621.78M 2025-09
Regeneron Pharmaceuticals USD 18.87B 16.36B 2025-12
Roche Holding CHF 7.55B 579M 2025-06
Sanofi EUR 7.66B 1.25B 2025-12
Sarepta Therapeutics USD 801.28M 188.2M 2025-12
Sartorius EUR 389.9M 429.1M 2025-09
Sino Biopharmaceutical CNY 3.38B 2.09B 2024-12
Tectonic Therapeutic USD 253.8M 14.64M 2025-12
Tilray USD 264.83M 43.16M 2025-06
Vanda Pharmaceuticals USD 84.85M 14.83M 2025-12
Zealand Pharma A/S 4.58B 1.4B 2025-12
Zz Pientze Pharmaceu CNY 1.77B 376.03M 2025-06